The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Solid Dosage Contract Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.
The global Pharmaceutical Solid Dosage Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Solid Dosage Contract Manufacturing in various end use industries. The expanding demands from the Instant Release, Sustained Release, Extended Release and Effervescent Tablets, are propelling Pharmaceutical Solid Dosage Contract Manufacturing market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Solid Dosage Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Solid Dosage Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Solid Dosage Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Solid Dosage Contract Manufacturing covered in this report include Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Alkermes, BioPharma Solutions, Cytovance Biologics, DPT Laboratories, Fresenius Kabi and Halo Pharmaceutical, etc.
The global Pharmaceutical Solid Dosage Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions
Global Pharmaceutical Solid Dosage Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Solid Dosage Contract Manufacturing market, Segment by Type:
Tablets
Capsule
Lozenge
Powder
Others
Global Pharmaceutical Solid Dosage Contract Manufacturing market, by Application
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.
The global Pharmaceutical Solid Dosage Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Solid Dosage Contract Manufacturing in various end use industries. The expanding demands from the Instant Release, Sustained Release, Extended Release and Effervescent Tablets, are propelling Pharmaceutical Solid Dosage Contract Manufacturing market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Solid Dosage Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Solid Dosage Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Solid Dosage Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Solid Dosage Contract Manufacturing covered in this report include Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Alkermes, BioPharma Solutions, Cytovance Biologics, DPT Laboratories, Fresenius Kabi and Halo Pharmaceutical, etc.
The global Pharmaceutical Solid Dosage Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions
Global Pharmaceutical Solid Dosage Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Solid Dosage Contract Manufacturing market, Segment by Type:
Tablets
Capsule
Lozenge
Powder
Others
Global Pharmaceutical Solid Dosage Contract Manufacturing market, by Application
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Solid Dosage Contract Manufacturing
1.1 Pharmaceutical Solid Dosage Contract Manufacturing Market Overview
1.1.1 Pharmaceutical Solid Dosage Contract Manufacturing Product Scope
1.1.2 Pharmaceutical Solid Dosage Contract Manufacturing Market Status and Outlook
1.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2018-2029)
2 Pharmaceutical Solid Dosage Contract Manufacturing Market by Type
2.1 Introduction
2.1.1 Tablets
2.1.2 Capsule
2.1.3 Lozenge
2.1.4 Powder
2.1.5 Others
2.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Solid Dosage Contract Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Instant Release
3.1.2 Sustained Release
3.1.3 Extended Release
3.1.4 Effervescent Tablets
3.1.5 Chewable Tablets
3.1.6 Enteric Release
3.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Solid Dosage Contract Manufacturing Competition Analysis by Players
4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Solid Dosage Contract Manufacturing as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Solid Dosage Contract Manufacturing Market
4.4 Global Top Players Pharmaceutical Solid Dosage Contract Manufacturing Headquarters and Area Served
4.5 Key Players Pharmaceutical Solid Dosage Contract Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Solid Dosage Contract Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.1.4 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Catalent Pharma Solutions
5.2.1 Catalent Pharma Solutions Profile
5.2.2 Catalent Pharma Solutions Main Business
5.2.3 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.2.4 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Catalent Pharma Solutions Recent Developments
5.3 Jubilant Life Sciences Limited
5.3.1 Jubilant Life Sciences Limited Profile
5.3.2 Jubilant Life Sciences Limited Main Business
5.3.3 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.3.4 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Alkermes Recent Developments
5.4 Alkermes
5.4.1 Alkermes Profile
5.4.2 Alkermes Main Business
5.4.3 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.4.4 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Alkermes Recent Developments
5.5 BioPharma Solutions
5.5.1 BioPharma Solutions Profile
5.5.2 BioPharma Solutions Main Business
5.5.3 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.5.4 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 BioPharma Solutions Recent Developments
5.6 Cytovance Biologics
5.6.1 Cytovance Biologics Profile
5.6.2 Cytovance Biologics Main Business
5.6.3 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.6.4 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Cytovance Biologics Recent Developments
5.7 DPT Laboratories
5.7.1 DPT Laboratories Profile
5.7.2 DPT Laboratories Main Business
5.7.3 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.7.4 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 DPT Laboratories Recent Developments
5.8 Fresenius Kabi
5.8.1 Fresenius Kabi Profile
5.8.2 Fresenius Kabi Main Business
5.8.3 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.8.4 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Fresenius Kabi Recent Developments
5.9 Halo Pharmaceutical
5.9.1 Halo Pharmaceutical Profile
5.9.2 Halo Pharmaceutical Main Business
5.9.3 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.9.4 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Halo Pharmaceutical Recent Developments
5.10 Lyophilization Technology
5.10.1 Lyophilization Technology Profile
5.10.2 Lyophilization Technology Main Business
5.10.3 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.10.4 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Lyophilization Technology Recent Developments
5.11 Mikart
5.11.1 Mikart Profile
5.11.2 Mikart Main Business
5.11.3 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.11.4 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Mikart Recent Developments
5.12 Pillar5 Pharma
5.12.1 Pillar5 Pharma Profile
5.12.2 Pillar5 Pharma Main Business
5.12.3 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.12.4 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Pillar5 Pharma Recent Developments
5.13 Haupt Pharma
5.13.1 Haupt Pharma Profile
5.13.2 Haupt Pharma Main Business
5.13.3 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.13.4 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Haupt Pharma Recent Developments
5.14 Althea Technologies
5.14.1 Althea Technologies Profile
5.14.2 Althea Technologies Main Business
5.14.3 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.14.4 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Althea Technologies Recent Developments
5.15 Associates of Cape Cod
5.15.1 Associates of Cape Cod Profile
5.15.2 Associates of Cape Cod Main Business
5.15.3 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.15.4 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 Associates of Cape Cod Recent Developments
5.16 Covance
5.16.1 Covance Profile
5.16.2 Covance Main Business
5.16.3 Covance Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.16.4 Covance Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.16.5 Covance Recent Developments
5.17 Emergent BioSolutions
5.17.1 Emergent BioSolutions Profile
5.17.2 Emergent BioSolutions Main Business
5.17.3 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Products, Services and Solutions
5.17.4 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.17.5 Emergent BioSolutions Recent Developments
6 North America
6.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Solid Dosage Contract Manufacturing Market Dynamics
11.1 Pharmaceutical Solid Dosage Contract Manufacturing Industry Trends
11.2 Pharmaceutical Solid Dosage Contract Manufacturing Market Drivers
11.3 Pharmaceutical Solid Dosage Contract Manufacturing Market Challenges
11.4 Pharmaceutical Solid Dosage Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
